Mosapride

Citrate is the active pharmaceutical ingredient.

Treatment of functional dyspepsia (symptoms like upper abdominal pain, fullness, early satiation)

Relief of symptoms associated with gastroparesis (delayed stomach emptying)

Moten Instab 2.5mg Tablet (Mosapride) is a prokinetic agent. It acts primarily as a selective 5-HT4 receptor agonist, enhancing cholinergic neurotransmission in the gastrointestinal tract. This promotes gastric emptying and accelerates intestinal transit, relieving symptoms associated with delayed gastric motility.

Store at room temperature (below 25°C) in a dry place, away from direct sunlight and moisture. Keep out of reach of children.

Dosage should be determined by a healthcare professional and adjusted based on individual needs and response.

Typically administered orally, with or without food.

Diarrhea

Nausea

Vomiting

Headache

Dizziness

Constipation (rare)

Allergic reactions (rare, may include rash, itching, swelling)

Alcohol Consumption

The combined effects of alcohol and mosapride have not been extensively studied. It's advisable to avoid alcohol consumption while taking mosapride.



While Driving or operating Machinery

Mosapride may cause dizziness or drowsiness in some individuals. Avoid driving or operating machinery until you know how this medication affects you.



Pregnant & Breastfeeding Women

Mosapride is generally not recommended during pregnancy and breastfeeding unless the benefits outweigh the potential risks. Consult your doctor.



Children

The safety and effectiveness of mosapride in children have not been fully established. It is generally not recommended for use in children.



Kidney

Dose adjustment may be necessary for patients with severe kidney impairment. Consult your doctor.



Liver

Dose adjustment may be necessary for patients with severe liver impairment. Consult your doctor.

This information is for general knowledge and does not constitute medical advice. Always consult a healthcare professional for diagnosis and treatment.